In the wake of the increase in Current Liabilities in the first quarter 2026, Quick Ratio fell to 0.09 below Aptose Biosciences Inc average.

Within Biotechnology & Pharmaceuticals industry 128 other companies have achieved higher Quick Ratio than Aptose Biosciences Inc in first quarter 2026. While Quick Ratio total ranking in the first quarter 2026 has deteriorated compared to the prior quarter from 2642 to 3276.

Explain Quick Ratio?
How much Cash & cash equivalents APTO�s has?
What are APTO�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

APTO Quick Ratio	(Mar 31 2026) Q1	(Dec 31 2025) Q4	(Sep 30 2025) Q3	(Jun 30 2025) Q2	(Mar 31 2025) Q1
Y / Y Current Liabilities Change	95.29 %	104.37 %	-32.99 %	-34.76 %	-51.33 %
Y / Y Cash & cash equivalent Change	-21.54 %	636.03 %	14.69 %	-81.91 %	-73.37 %
Quick Ratio MRQ	0.09	0.45	0.26	0.07	0.23
APTO's Total Ranking	# 3276	# 2642	# 3267	# 1381	#
Seq. Current Liabilities Change	22.45 %	45.58 %	-24.51 %	45.13 %	28.15 %
Seq. Cash & cash equivalent Change	-75.1 %	152.22 %	170.67 %	-53.85 %	133.6 %

Quick Ratio first quarter 2026 Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 129
Healthcare Sector	# 791
Overall Market	# 3276

Quick Ratio Statistics
High	Average	Low
27.05	8.16	0.07
(Sep 30 2020)		(Jun 30 2025)

Financial Statements
Aptose Biosciences Inc 's Current Liabilities	$ 11 Millions	Visit APTO's Balance sheet
Aptose Biosciences Inc 's Cash & cash equivalent	$ 1 Millions	Visit APTO's Balance sheet
Source of APTO's Sales		Visit APTO's Sales by Geography

Cumulative Aptose Biosciences Inc 's Quick Ratio

APTO's Quick Ratio for the trailling 12 Months

APTO Quick Ratio	(Mar 31 2026) 12 Months	(Dec 31 2025) 12 Months	(Sep 30 2025) 12 Months	(Jun 30 2025) 12 Months	(Mar 31 2025) 12 Months
Y / Y Current Liabilities TTM Growth	8.06 %	-23.19 %	-49.6 %	-46.63 %	-36.78 %
Y / Y Cash & cash equivalent TTM Growth	11.41 %	-25.07 %	-67.03 %	-73.56 %	-77.13 %
Quick Ratio TTM	0.21	0.26	0.17	0.14	0.2
Total Ranking TTM	# 3004	# 3368	# 2938	# 3367	#
Seq. Current Liabilities TTM Growth	18.53 %	18.82 %	-11.08 %	-13.71 %	-15.75 %
Seq. Cash & cash equivalent TTM Growth	-3.67 %	86.74 %	5.37 %	-41.22 %	-35.21 %

Quick ratio ranking by company, industry and sector >> Back to APTO Financial Strength Comparisons >> Go to Compare APTO Quick Ratio to its Competitors

On the trailing twelve months basis Due to growth in Current Liabilities in the Q1 2026 to $11.16 millions, cumulative Quick Ratio decreased to 0.21 below the Aptose Biosciences Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Biotechnology & Pharmaceuticals industry 132 other companies have achieved higher Quick Ratio than Aptose Biosciences Inc . While Quick Ratio overall ranking has improved so far to 3004, from total ranking during the twelve months ending fourth quarter 2025 at 3368.

Explain Quick Ratio?
How much Cash & cash equivalents APTO�s has?
What are APTO�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Biotechnology & Pharmaceuticals Industry	# 133
Healthcare Sector	# 822
Within the Market	# 3004

trailing twelve months Quick Ratio Statistics
High	Average	Low
19.61	7.88	0.24
(Mar 31 2021)		(Mar 31 2026)

Companies with similar Quick Ratio in the quarter ending Mar 31 2026, within Biotechnology & Pharmaceuticals Industry	Quick Ratio	Mar 31 2026 MRQ Cash & cash equivalent	Mar 31 2026 MRQ Current Liabilities
Champions Oncology Inc	0.24	$ 4.872 Millions	$ 19.922 Millions
Outlook Therapeutics Inc	0.20	$ 7.748 Millions	$ 38.884 Millions
Agenus Inc	0.14	$ 34.996 Millions	$ 249.237 Millions
Vaxart Inc	0.13	$ 10.276 Millions	$ 76.842 Millions
ADAPTIN BIO, INC.	0.11	$ 0.301 Millions	$ 2.792 Millions
Tevogen Bio Holdings Inc	0.10	$ 0.692 Millions	$ 6.941 Millions
Aptose Biosciences Inc	0.09	$ 1.020 Millions	$ 11.159 Millions
Bioatla Inc	0.08	$ 1.961 Millions	$ 23.633 Millions
Black Hawk Acquisition Corporation	0.05	$ 0.178 Millions	$ 3.645 Millions

Date modified: 2026-06-23T17:39:04+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.